Publications

5674 Results

Effectiveness of a media based launch to recruit to a prostate cancer prevention trial

Authors
L Minasian;K Smigel-Croker;A Ryan;A Voss;L Cave;E Klein;L Ford
Journal / Conference
Controlled Clinical Trials 24(3S)Suppl:50S (#14)
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

HLA D3(7) confers a poor prognosis in intermediate thickness (1.5-4.0mm) melanoma: serotyping of 553 patients on SWOG 9035.

Authors
JA Sosman;J Unger;JE Lee;P Liu;L Flaherty;VK Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 22:710(#2856)
Year
2003
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

High dose dexamethasone (Dex) with maintenance Dex/alpha interferon lead to improved survival in patients with primary systemic amyloidosis: results of US Intergroup Trial Southwest Oncology Group (SWOG) S9628.

Authors
M Dhodapkar;J Jacobson;M Hussein;RA Larson;J Crowley;A Solomon;B Barlogie
Journal / Conference
Proc of the American Society of Clinical Oncology 22:566(#2278)
Year
2003
Research Committee(s)
Myeloma
Study Number(s)
S9628

Induction chemoradiotherapy and surgical resection for non-small cell lung carcinomas of the superior sulcus (pancoast tumors): mature results of Southwest Oncology Group trial 9416 (Intergroup trial 0160)

Authors
VW Rusch;D Giroux;MJ Kraut;J Crowley;M Hazuka;DH Johnson;L Shulman;F Shepherd;D Deschamps;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 22:634(#2548)
Year
2003
Research Committee(s)
Lung
Study Number(s)
SWOG-9416

Optimizing data collection in a large web-based trial

Authors
KB Gower;A Darke
Journal / Conference
Controlled Clinical Trials 24(3S):47S(#10)
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Planning for successful recruitment for cancer trials

Authors
K Anderson;J Probstfield;SM Thomas
Journal / Conference
Controlled Clinical Trials 24(3S)Suppl:102S(#P18)
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Challenges of implementing ancillary studies within multi-site clinical trials

Authors
T Chay;P Goodman;J Hartline
Journal / Conference
Controlled Clinical Trials24(3S)Suppl:182S(#P173)
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Form and function: PDF+ versus HTML form design

Authors
K Gower;B Kleinman
Journal / Conference
Controlled Clinical Trials 24(3S)Suppl:188A(#P186)
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Drug distribution challenges in a multi-site clinical trial

Authors
A Darke;J Vertrees;P Goodman
Journal / Conference
Controlled Clinical Trials 24(3S)Suppl:203S(#P217)
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Authors
A Rosenwald;G Wright;A Wiestner;WC Chan;JM Connors;E Campo;RD Gascoyne;TM Grogan;HK Muller-Hermelink;EB Smeland;M Chiorazzi;JM Giltnane;EM Hurt;H Zhao;L Averett;S Henrickson;L Yang;J Powell;WH Wilson;ES Jaffe;R Simon;RD Klausner;E Montserrat;F Bosch;TC Greiner;DD Weisenburger;WG Sanger;BJ Dave;JC Lynch;J Vose;JO Armitage;RI Fisher;TP Miller;M LeBlanc;G Ott;S Kvaloy;H Holte;H Delabie;LM Staudt
Journal / Conference
Cancer Cell 3:185-197
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819